310 related articles for article (PubMed ID: 16406402)
21. Amphotericin B aggregation inhibition with novel nanoparticles prepared with poly(epsilon-caprolactone)/poly(n,n-dimethylamino-2-ethyl methacrylate) diblock copolymer.
Shim YH; Kim YC; Lee HJ; Bougard F; Dubois P; Choi KC; Chung CW; Kang DH; Jeong YI
J Microbiol Biotechnol; 2011 Jan; 21(1):28-36. PubMed ID: 21301189
[TBL] [Abstract][Full Text] [Related]
22. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
23. Novel composite drug delivery system for honokiol delivery: self-assembled poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) micelles in thermosensitive poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) hydrogel.
Gong C; Shi S; Wang X; Wang Y; Fu S; Dong P; Chen L; Zhao X; Wei Y; Qian Z
J Phys Chem B; 2009 Jul; 113(30):10183-8. PubMed ID: 19572675
[TBL] [Abstract][Full Text] [Related]
24. pH-controlled, polymer-mediated assembly of polymer micelle nanoparticles.
Lee SC; Lee HJ
Langmuir; 2007 Jan; 23(2):488-95. PubMed ID: 17209598
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable and thermoreversible hydrogels of poly(ethylene glycol)-poly(epsilon-caprolactone-co-glycolide)-poly(ethylene glycol) aqueous solutions.
Jiang Z; Hao J; You Y; Liu Y; Wang Z; Deng X
J Biomed Mater Res A; 2008 Oct; 87(1):45-51. PubMed ID: 18080306
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo safety evaluation of biodegradable self-assembled monomethyl poly (ethylene glycol)-poly (ε-caprolactone)-poly (trimethylene carbonate) micelles.
Yang X; Cao D; Wang N; Sun L; Li L; Nie S; Wu Q; Liu X; Yi C; Gong C
J Pharm Sci; 2014 Jan; 103(1):305-13. PubMed ID: 24282070
[TBL] [Abstract][Full Text] [Related]
27. Linolenic acid-modified MPEG-PEI micelles for encapsulation of amphotericin B.
Xu H; Teng F; Zhou F; Zhu L; Wen Y; Feng R; Song Z
Future Med Chem; 2019 Oct; 11(20):2647-2662. PubMed ID: 31621420
[No Abstract] [Full Text] [Related]
28. Chemical modification of hydrophobic block in poly(ethylene oxide) poly(caprolactone) based nanocarriers: effect on the solubilization and hemolytic activity of amphotericin B.
Falamarzian A; Lavasanifar A
Macromol Biosci; 2010 Jun; 10(6):648-56. PubMed ID: 20352627
[TBL] [Abstract][Full Text] [Related]
29. Reformulation of Fungizone by PEG-DSPE Micelles: Deaggregation and Detoxification of Amphotericin B.
Alvarez C; Shin DH; Kwon GS
Pharm Res; 2016 Sep; 33(9):2098-106. PubMed ID: 27198671
[TBL] [Abstract][Full Text] [Related]
30. Passive diffusion of polymeric surfactants across lipid bilayers.
Mathot F; Schanck A; Van Bambeke F; Ariën A; Noppe M; Brewster M; Préat V
J Control Release; 2007 Jul; 120(1-2):79-87. PubMed ID: 17524515
[TBL] [Abstract][Full Text] [Related]
31. PEG-b-PPS diblock copolymer aggregates for hydrophobic drug solubilization and release: cyclosporin A as an example.
Velluto D; Demurtas D; Hubbell JA
Mol Pharm; 2008; 5(4):632-42. PubMed ID: 18547055
[TBL] [Abstract][Full Text] [Related]
32. Mixed micellar nanoparticle of amphotericin B and poly styrene-block-poly ethylene oxide reduces nephrotoxicity but retains antifungal activity.
Han K; Miah MA; Shanmugam S; Yong CS; Choi HG; Kim JA; Yoo BK
Arch Pharm Res; 2007 Oct; 30(10):1344-9. PubMed ID: 18038914
[TBL] [Abstract][Full Text] [Related]
33. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
34. A novel use of an in vitro method to predict the in vivo stability of block copolymer based nano-containers.
Aliabadi HM; Brocks DR; Mahdipoor P; Lavasanifar A
J Control Release; 2007 Sep; 122(1):63-70. PubMed ID: 17644207
[TBL] [Abstract][Full Text] [Related]
35. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A.
Aliabadi HM; Mahmud A; Sharifabadi AD; Lavasanifar A
J Control Release; 2005 May; 104(2):301-11. PubMed ID: 15907581
[TBL] [Abstract][Full Text] [Related]
36. Preparation and Characterizations of RSPP050-Loaded Polymeric Micelles Using Poly(ethylene glycol)-b-Poly(ε-caprolactone) and Poly(ethylene glycol)-b-Poly(D,L-lactide).
Eawsakul K; Chinavinijkul P; Saeeng R; Chairoungdua A; Tuchinda P; Nasongkla N
Chem Pharm Bull (Tokyo); 2017; 65(6):530-537. PubMed ID: 28566645
[TBL] [Abstract][Full Text] [Related]
37. pH-induced micelle formation of poly(histidine-co-phenylalanine)-block-poly(ethylene glycol) in aqueous media.
Kim GM; Bae YH; Jo WH
Macromol Biosci; 2005 Nov; 5(11):1118-24. PubMed ID: 16245269
[TBL] [Abstract][Full Text] [Related]
38. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles.
Elhasi S; Astaneh R; Lavasanifar A
Eur J Pharm Biopharm; 2007 Mar; 65(3):406-13. PubMed ID: 17291732
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of self-assembled nanoparticles formed by poly(ethylene oxide)-block-poly(epsilon-caprolactone) copolymers with long poly(epsilon-caprolactone) blocks in aqueous solutions.
Sachl R; Uchman M; Matĕjícek P; Procházka K; Stĕpánek M; Spírková M
Langmuir; 2007 Mar; 23(6):3395-400. PubMed ID: 17269809
[TBL] [Abstract][Full Text] [Related]
40. Linolenic acid-modified methoxy poly (ethylene glycol)-oligochitosan conjugate micelles for encapsulation of amphotericin B.
Song Z; Wen Y; Deng P; Teng F; Zhou F; Xu H; Feng S; Zhu L; Feng R
Carbohydr Polym; 2019 Feb; 205():571-580. PubMed ID: 30446143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
